Udhghatri Kolli
Overview
Explore the profile of Udhghatri Kolli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vitari N, Singh S, Tao J, Truitt B, Kolli U, Jalodia R, et al.
Gut Microbes
. 2024 Oct;
16(1):2417729.
PMID: 39441178
IgA binding dictates the composition of the intestinal microbiome and reflects dysbiotic states during chronic disease. Both pathogenic and commensal bacteria differentially bind to IgA with varying outcomes. Little is...
2.
Kolli U, Roy S
Front Microbiol
. 2023 Sep;
14:1233194.
PMID: 37670983
The current opioid pandemic is a major public health crisis in the United States, affecting millions of people and imposing significant health and socioeconomic burdens. Preclinical and clinical research over...
3.
Kolli U, Jalodia R, Moidunny S, Singh P, Ban Y, Tao J, et al.
Gut Microbes
. 2023 Aug;
15(2):2246184.
PMID: 37610102
Opioid crisis is an ongoing epidemic since the past several decades in the United States. Opioid use-associated microbial dysbiosis is emerging as a key regulator of intestinal homeostasis and behavioral...
4.
Jalodia R, Kolli U, Braniff R, Tao J, Abu Y, Chupikova I, et al.
Gut Microbes
. 2022 Nov;
14(1):2143225.
PMID: 36409161
The gut microbial ecosystem exhibits a complex bidirectional communication with the host and is one of the key contributing factors in determining mucosal immune homeostasis or an inflammatory state. Opioid...
5.
Jalodia R, Abu Y, Oppenheimer M, Herlihy B, Meng J, Chupikova I, et al.
J Neuroimmune Pharmacol
. 2022 Jan;
17(1-2):76-93.
PMID: 34993905
Opioid use disorder (OUD) is defined as the chronic use or misuse of prescribed or illicitly obtained opioids and is characterized by clinically significant impairment. The etiology of OUD is...
6.
Abu Y, Tao J, Dutta R, Yan Y, Vitari N, Kolli U, et al.
J Neuroimmune Pharmacol
. 2021 Sep;
17(1-2):367-375.
PMID: 34562195
Prenatal opioid exposure is associated with significantly adverse medical, developmental, and behavioral outcomes in offspring, though the underlying mechanisms driving these impairments are still unclear. Accumulating evidence implicates gut microbial...
7.
Moidunny S, Benneyworth M, Titus D, Beurel E, Kolli U, Meints J, et al.
Br J Pharmacol
. 2020 Oct;
177(24):5658-5676.
PMID: 33080056
Background And Purpose: A significant number of HIV-1 patients on antiretroviral therapy develop HIV-associated neurocognitive disorders (HAND). Evidence indicate that biological sex may regulate HAND pathogenesis, but the mechanisms remain...